Progress in HPV Vaccination in Low- and Lower-Middle-Income Countries
This article, published in the International Journal of Gynecology & Obstetrics, examines the experiences of low- and lower-middle-income countries (LLMICs) with human papillomavirus (HPV) vaccine introduction, and presents Senegal's experience as an illustrative country case study. The authors draw on recent summaries of global HPV vaccine delivery experiences in the published literature and from technical and policy documents of key international organizations, which demonstrate the overall acceptability and feasibility of HPV vaccinations in LLMICs. Political, programmatic, and financial sustainability remain key challenges to national scale-up. Advances in policy, programming, and science have the potential to amplify current efforts by LLMICs toward achieving Gavi, the Vaccine Alliance’s goal of reaching 30 million girls with HPV vaccine by 2020.
Author: LaMontagne DS, Bloem PJN, Brotherton JML, Gallagher KE, Badiane O, Ndiaye C.
» Visit web page (English)
(Located at onlinelibrary.wiley.com)
Citation: LaMontagne DS, Bloem PJN, Brotherton JML, Gallagher KE, Badiane O, Ndiaye C. Progress in HPV Vaccination in Low- and Lower-Middle-Income Countries. International Journal of Gynecology & Obstetrics. 2017;138(Suppl 1):7-14.
Resource types: Peer-reviewed journal
Diseases/vaccines: Human papillomavirus (HPV)